Enlitic has launched its cloud-based Ensight platform in the US through a phased deployment with Radiology Imaging Associates, generating an initial annual recurring revenue of approximately US$50,000 and setting the stage for broader expansion.
Telix Pharmaceuticals has gained UK MHRA approval for Illuccix, its advanced prostate cancer PET imaging agent, promising to alleviate supply shortages and improve diagnostic accuracy across the UK.